drugset / Trial / NCT03580902
CBT4CBT for Office Based Buprenorphine
RandomizedParallel-groupOpen-labelTreatment
Summary
In this Phase II SBIR/STTR project, our Specific Aim will be to determine if the use of CBT4CBT-Buprenorphine leads to clinically significant improved outcomes and increased retention for buprenorphine maintenance patients in a larger and diverse population of individuals seeking buprenorphine treatment in primary care (N=100).
Timeline
- Start
- 2019-01-22
- Primary completion
- 2021-11-23
- Completion
- 2022-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Background | Naloxone | Small molecule | — | — |